查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566005

蛋白質結合檢測市場 - 全球規模、佔有率、趨勢分析、機會、預測，2019-2030 年

Protein Binding Assays Market, By Technology; By Products & Services; By End User; By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa ), Global Trend Analysis, Competitive Landscape & Forecast, 2019-2030
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球蛋白質結合檢測市場將以約 10% 的複合年成長率擴大，到 2030 年將超過 8.53 億美元

由於藥物發現和藥物開發活動的活性化、慢性病的增加、藥物研發投資的增加以及結合技術和方法的進步，全球蛋白質結合測定市場正在蓬勃發展。

領先的策略諮詢和市場研究公司 BlueWeave Consulting 在最近的一項研究中以金額為準，2023 年全球蛋白結合檢測市場規模為 4.4452 億美元。 BlueWeave 預測，在 2024 年至 2030 年的預測期內，全球蛋白質結合檢測市場規模將以 9.77% 的複合年成長率成長，到 2030 年將達到 8.5353 億美元。蛋白質結合檢測的全球市場由幾個關鍵因素推動，包括藥物發現的進步、對蛋白質-蛋白質相互作用的了解的加深以及對個人化醫療的需求不斷增加。此外，高通量篩檢和螢光檢測的技術進步正在提高這些檢測的效率和準確性。製藥和生物技術行業的崛起以及藥物開發的不斷努力進一步推動了全球蛋白質結合檢測市場的成長。

機會 - 擴展到伴同性診斷

伴同性診斷的日益普及預計將在分析期間促進全球蛋白質結合分析市場的複合年成長率的成長。隨著個人化醫療的發展，伴同性診斷擴大被用來預測患者對特定治療的反應。這種擴展需要準確的蛋白質結合測定來評估藥物-蛋白質交互作用，這對於確定藥物功效和安全性非常重要。將這些檢測方法整合到伴同性診斷中正在增加它們在藥物開發中的相關性並推動市場開拓。

地緣政治緊張局勢加劇對全球蛋白質結合檢測市場的影響

地緣政治緊張局勢的加劇可能會影響供應鏈、增加原料成本並導致生產和分銷延遲，從而擾亂全球蛋白質結合檢測市場。貿易限制和製裁可能會限制關鍵成分的獲取，而市場不確定性可能會減少研發投資。此外，地緣政治的不穩定性可能會將市場重點轉向國內採購，從而影響區域市場動態並減緩產業對新技術的採用。

生物製藥公司在最終用戶中佔有最大佔有率

製藥和生物技術公司是全球蛋白質結合測定市場最大的最終用戶。由於對藥物發現和市場開發過程的高需求（蛋白質結合測量在其中發揮關鍵作用），生物製藥公司佔據了市場主導地位。對個人化醫療的日益關注以及全球製藥和生物技術公司的激增對該行業的市場主導地位做出了重大貢獻。全球蛋白質結合檢測市場的其他主要最終用戶包括 CRO 和顧問公司。

競爭格局

全球蛋白質結合檢測市場競爭激烈，許多公司競相擴大市場佔有率。市場的主要企業包括 Thermo Fisher Scientific, Inc.、Charles River、Sovicell GMBH、XenoTech、GE Healthcare、Eurofins Scientific、Creative Biolabs、Evotec (Cyprotex)、Bioduro、BioAgilytix Labs、WuXi AppTec 和 Domainex。這些公司正在利用各種策略，例如增加研發活動投資、併購、合資、聯盟、許可協議以及新產品和服務發布，以進一步鞏固自己在全球蛋白質結合測定市場的地位。

該報告的詳細分析提供了有關全球蛋白質結合測定市場的成長潛力、未來趨勢和統計數據的資訊。我們也研究了推動市場總規模預測的因素。該報告致力於提供全球蛋白質結合測定市場的最新技術趨勢和產業見解，以幫助決策者做出明智的策略決策。此外，我們也分析了市場的成長動力、挑戰和競爭力。

目錄

第1章 研究框架

第 2 章執行摘要

第3章全球蛋白質結合分析市場洞察

  • 產業價值鏈分析
  • DROC分析
    • 生長促進因子
      • 增加藥物發現和開發活動
      • 慢性病流行
      • 個人化醫療日益受到關注
    • 抑制因素
      • 與檢測開發和檢驗相關的高成本
      • 蛋白質-藥物交互作用的複雜性
      • 耗時的分析步驟
    • 機會
      • 生物相似藥和生技改良藥的開發
      • 擴展到伴同性診斷
      • 開發新的檢測平台
    • 任務
      • 分析技術和方法的保護
      • 從蛋白質結合資料中提取有意義的見解
      • 標準化通訊協定的可用性有限
  • 科技進步/最新趨勢
  • 法律規範
  • 波特五力分析

第4章全球蛋白質結合測定市場：行銷策略

第5章全球蛋白質結合檢測市場：價格分析

第6章全球蛋白質結合分析市場：區域分析

  • 全球蛋白質結合檢測市場，區域分析，2023 年
  • 全球蛋白質結合分析市場，吸引力分析，2024-2030

第7章全球蛋白質結合測定市場概述

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依技術
      • 平衡透析
      • 親和電泳
      • 超過濾
      • 超速離心
      • 表面等離子體共振
      • 其他
    • 按產品和服務
      • 裝置
      • 試劑套件和試劑
      • 服務
    • 按最終用戶
      • 製藥和生物技術公司
      • CRO
      • 顧問公司
      • 其他
    • 按地區
      • 北美洲
      • 歐洲
      • 亞太地區 (APAC)
      • 拉丁美洲 (LATAM)
      • 中東和非洲（中東/非洲）

第8章北美蛋白質結合檢測市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依技術
    • 按產品/服務
    • 按最終用戶
    • 按國家/地區
      • 美國
      • 加拿大

第9章歐洲蛋白質結合檢測市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依技術
    • 按產品/服務
    • 按最終用戶
    • 按國家/地區
      • 德國
      • 英國
      • 義大利
      • 法國
      • 西班牙
      • 比利時
      • 俄羅斯
      • 荷蘭
      • 其他歐洲國家

第10章亞太地區蛋白質結合分析市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依技術
    • 按產品/服務
    • 按最終用戶
    • 按國家/地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 澳洲和紐西蘭
      • 印尼
      • 馬來西亞
      • 新加坡
      • 越南
      • 亞太地區其他國家

第11章拉丁美洲蛋白質結合檢測市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依技術
    • 按產品/服務
    • 按最終用戶
    • 按國家/地區
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘魯
      • 其他拉丁美洲

第12章中東和非洲蛋白質結合檢測市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依技術
    • 按產品/服務
    • 按最終用戶
    • 按國家/地區
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 科威特
      • 南非
      • 奈及利亞
      • 阿爾及利亞
      • 中東和非洲其他地區

第13章競爭格局

  • 主要企業及其產品列表
  • 2023年全球蛋白質結合檢測公司市場佔有率分析
  • 透過管理參數進行競爭基準基準化分析
  • 主要策略發展（合併、收購、聯盟）

第14章地緣政治緊張局勢加劇對全球蛋白質結合檢測市場的影響

第15章 公司簡介（公司簡介、財務矩陣、競爭格局、關鍵人員、主要競爭對手、聯絡方式、策略展望、SWOT分析）

  • Thermo Fisher Scientific, Inc.
  • Charles River
  • Sovicell GMBH
  • XenoTech
  • GE Healthcare
  • Eurofins Scientific
  • Creative Biolabs
  • Evotec（Cyprotex）
  • Bioduro
  • BioAgilytix Labs
  • WuXi AppTec
  • Domainex
  • 其他主要企業

第16章 主要策略建議

第17章調查方法

簡介目錄
Product Code: BWC24635

Global Protein Binding Assays Market Expands at CAGR of almost 10% to Surpass Value of USD 853 Million by 2030

Global Protein Binding Assays Market is thriving due to rising drug discovery and development activities, increasing prevalence of chronic diseases, growing pharmaceutical R&D investments, and advancements in binding technologies and techniques.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Global Protein Binding Assays Market size by value at USD 444.52 million in 2023. During the forecast period between 2024 and 2030, BlueWeave expects Global Protein Binding Assays Market size to expand at a CAGR of 9.77% reaching a value of USD 853.53 million in 2030. Global Protein Binding Assays Market is driven by several key factors including advancements in drug discovery, a growing understanding of protein-protein interactions, and the increasing demand for personalized medicine. Additionally, technological advancements in high-throughput screening and fluorescence-based assays enhance the efficiency and accuracy of these assays. The rising pharmaceutical and biotechnology industries, along with continuous efforts in drug development, further propel the growth of Global Protein Binding Assays Market.

Opportunity - Expansion into Companion Diagnostics

The growing adoption of companion diagnostics is expected to boost the growth of Global Protein Binding Assays Market at a significant CAGR during the period in analysis. As personalized medicine gains momentum, companion diagnostics are increasingly used to predict patient response to specific therapies. The expansion requires accurate protein binding assays to assess drug-protein interactions, which are critical in determining drug efficacy and safety. The integration of these assays into companion diagnostics enhances their relevance in drug development, driving market growth.

Impact of Escalating Geopolitical Tensions on Global Protein Binding Assays Market

Escalating geopolitical tensions can disrupt the Global Protein Binding Assays Market by affecting supply chains, increasing costs of raw materials, and causing delays in production and distribution. Trade restrictions and sanctions may limit access to critical components, while market uncertainty could lead to reduced investment in research and development. Additionally, geopolitical instability may shift market focus toward domestic sourcing, influencing regional market dynamics and potentially slowing the adoption of new technologies in the industry.

Biopharma Companies Hold Largest Share in Market by End User

The pharmaceutical and biotechnology companies segment is the largest end user segment in Global Protein Binding Assays Market. Biopharma companies dominate the market due to the high demand for drug discovery and development processes, where protein binding assays play a critical role. The increasing focus on personalized medicine and the growing number of pharmaceutical and biotech firms globally contribute significantly to the segment's dominance in the market. The other major end user segments in Global Protein Binding Assays Market include CROs and consulting firms.

Competitive Landscape

Global Protein Binding Assays Market is fiercely competitive, with numerous companies vying for a larger market share. Major companies in the market include Thermo Fisher Scientific, Inc., Charles River, Sovicell GMBH, XenoTech, GE Healthcare, Eurofins Scientific, Creative Biolabs, Evotec (Cyprotex), Bioduro, BioAgilytix Labs, WuXi AppTec, and Domainex. These companies use various strategies, including increasing investments in their R&D activities, mergers and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in Global Protein Binding Assays Market.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Protein Binding Assays Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Protein Binding Assays Market and industry insights to help decision-makers make sound strategic decisions. Further, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Protein Binding Assays Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Increasing drug discovery and development activities
      • 3.2.1.2. Rising prevalence of chronic diseases
      • 3.2.1.3. Growing emphasis on personalized medicine
    • 3.2.2. Restraints
      • 3.2.2.1. High costs associated with assay development and validation
      • 3.2.2.2. Complex nature of protein-drug interactions
      • 3.2.2.3. Time-consuming assay procedures
    • 3.2.3. Opportunities
      • 3.2.3.1. Development of biosimilars and bio betters
      • 3.2.3.2. Expansion into companion diagnostics
      • 3.2.3.3. Development of novel assay platforms
    • 3.2.4. Challenges
      • 3.2.4.1. Protecting assay technologies and methods
      • 3.2.4.2. Extracting meaningful insights from protein binding data
      • 3.2.4.3. Limited availability of standardized protocols
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Protein Binding Assays Market: Marketing Strategies

5. Global Protein Binding Assays Market: Pricing Analysis

6. Global Protein Binding Assays Market: Geography Analysis

  • 6.1. Global Protein Binding Assays Market, Geographical Analysis, 2023
  • 6.2. Global Protein Binding Assays, Market Attractiveness Analysis, 2024-2030

7. Global Protein Binding Assays Market Overview

  • 7.1. Market Size & Forecast, 2019-2030
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
      • 7.2.1.1. Equilibrium Dialysis
      • 7.2.1.2. Affinity Electrophoresis
      • 7.2.1.3. Ultrafiltration
      • 7.2.1.4. Ultracentrifugation
      • 7.2.1.5. Surface Plasmon Resonance
      • 7.2.1.6. Others
    • 7.2.2. By Products and Services
      • 7.2.2.1. Instruments
      • 7.2.2.2. Kits & Reagents
      • 7.2.2.3. Services
    • 7.2.3. By End User
      • 7.2.3.1. Pharmaceutical & Biotechnology Companies
      • 7.2.3.2. CROs
      • 7.2.3.3. Consulting Firms
      • 7.2.3.4. Others
    • 7.2.4. By Region
      • 7.2.4.1. North America
      • 7.2.4.2. Europe
      • 7.2.4.3. Asia Pacific (APAC)
      • 7.2.4.4. Latin America (LATAM)
      • 7.2.4.5. Middle East and Africa (MEA)

8. North America Protein Binding Assays Market

  • 8.1. Market Size & Forecast, 2019-2030
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Product and Services
    • 8.2.3. By End User
    • 8.2.4. By Country
      • 8.2.4.1. United States
      • 8.2.4.1.1. By Technology
      • 8.2.4.1.2. By Product and Services
      • 8.2.4.1.3. By End User
      • 8.2.4.2. Canada
      • 8.2.4.2.1. By Technology
      • 8.2.4.2.2. By Product and Services
      • 8.2.4.2.3. By End User

9. Europe Protein Binding Assays Market

  • 9.1. Market Size & Forecast, 2019-2030
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Product and Services
    • 9.2.3. By End User
    • 9.2.4. By Country
      • 9.2.4.1. Germany
      • 9.2.4.1.1. By Technology
      • 9.2.4.1.2. By Product and Services
      • 9.2.4.1.3. By End User
      • 9.2.4.2. United Kingdom
      • 9.2.4.2.1. By Technology
      • 9.2.4.2.2. By Product and Services
      • 9.2.4.2.3. By End User
      • 9.2.4.3. Italy
      • 9.2.4.3.1. By Technology
      • 9.2.4.3.2. By Product and Services
      • 9.2.4.3.3. By End User
      • 9.2.4.4. France
      • 9.2.4.4.1. By Technology
      • 9.2.4.4.2. By Product and Services
      • 9.2.4.4.3. By End User
      • 9.2.4.5. Spain
      • 9.2.4.5.1. By Technology
      • 9.2.4.5.2. By Product and Services
      • 9.2.4.5.3. By End User
      • 9.2.4.6. Belgium
      • 9.2.4.6.1. By Technology
      • 9.2.4.6.2. By Product and Services
      • 9.2.4.6.3. By End User
      • 9.2.4.7. Russia
      • 9.2.4.7.1. By Technology
      • 9.2.4.7.2. By Product and Services
      • 9.2.4.7.3. By End User
      • 9.2.4.8. The Netherlands
      • 9.2.4.8.1. By Technology
      • 9.2.4.8.2. By Product and Services
      • 9.2.4.8.3. By End User
      • 9.2.4.9. Rest of Europe
      • 9.2.4.9.1. By Technology
      • 9.2.4.9.2. By Product and Services
      • 9.2.4.9.3. By End User

10. Asia Pacific Protein Binding Assays Market

  • 10.1. Market Size & Forecast, 2019-2030
    • 10.1.1. By Value (USD Million)
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technology
    • 10.2.2. By Product and Services
    • 10.2.3. By End User
    • 10.2.4. By Country
      • 10.2.4.1. China
      • 10.2.4.1.1. By Technology
      • 10.2.4.1.2. By Product and Services
      • 10.2.4.1.3. By End User
      • 10.2.4.2. India
      • 10.2.4.2.1. By Technology
      • 10.2.4.2.2. By Product and Services
      • 10.2.4.2.3. By End User
      • 10.2.4.3. Japan
      • 10.2.4.3.1. By Technology
      • 10.2.4.3.2. By Product and Services
      • 10.2.4.3.3. By End User
      • 10.2.4.4. South Korea
      • 10.2.4.4.1. By Technology
      • 10.2.4.4.2. By Product and Services
      • 10.2.4.4.3. By End User
      • 10.2.4.5. Australia & New Zealand
      • 10.2.4.5.1. By Technology
      • 10.2.4.5.2. By Product and Services
      • 10.2.4.5.3. By End User
      • 10.2.4.6. Indonesia
      • 10.2.4.6.1. By Technology
      • 10.2.4.6.2. By Product and Services
      • 10.2.4.6.3. By End User
      • 10.2.4.7. Malaysia
      • 10.2.4.7.1. By Technology
      • 10.2.4.7.2. By Product and Services
      • 10.2.4.7.3. By End User
      • 10.2.4.8. Singapore
      • 10.2.4.8.1. By Technology
      • 10.2.4.8.2. By Product and Services
      • 10.2.4.8.3. By End User
      • 10.2.4.9. Vietnam
      • 10.2.4.9.1. By Technology
      • 10.2.4.9.2. By Product and Services
      • 10.2.4.9.3. By End User
      • 10.2.4.10. Rest of APAC
      • 10.2.4.10.1. By Technology
      • 10.2.4.10.2. By Product and Services
      • 10.2.4.10.3. By End User

11. Latin America Protein Binding Assays Market

  • 11.1. Market Size & Forecast, 2019-2030
    • 11.1.1. By Value (USD Million)
  • 11.2. Market Share & Forecast
    • 11.2.1. By Technology
    • 11.2.2. By Product and Services
    • 11.2.3. By End User
    • 11.2.4. By Country
      • 11.2.4.1. Brazil
      • 11.2.4.1.1. By Technology
      • 11.2.4.1.2. By Product and Services
      • 11.2.4.1.3. By End User
      • 11.2.4.2. Mexico
      • 11.2.4.2.1. By Technology
      • 11.2.4.2.2. By Product and Services
      • 11.2.4.2.3. By End User
      • 11.2.4.3. Argentina
      • 11.2.4.3.1. By Technology
      • 11.2.4.3.2. By Product and Services
      • 11.2.4.3.3. By End User
      • 11.2.4.4. Peru
      • 11.2.4.4.1. By Technology
      • 11.2.4.4.2. By Product and Services
      • 11.2.4.4.3. By End User
      • 11.2.4.5. Rest of LATAM
      • 11.2.4.5.1. By Technology
      • 11.2.4.5.2. By Product and Services
      • 11.2.4.5.3. By End User

12. Middle East & Africa Protein Binding Assays Market

  • 12.1. Market Size & Forecast, 2019-2030
    • 12.1.1. By Value (USD Million)
  • 12.2. Market Share & Forecast
    • 12.2.1. By Technology
    • 12.2.2. By Product and Services
    • 12.2.3. By End User
    • 12.2.4. By Country
      • 12.2.4.1. Saudi Arabia
      • 12.2.4.1.1. By Technology
      • 12.2.4.1.2. By Product and Services
      • 12.2.4.1.3. By End User
      • 12.2.4.2. UAE
      • 12.2.4.2.1. By Technology
      • 12.2.4.2.2. By Product and Services
      • 12.2.4.2.3. By End User
      • 12.2.4.3. Qatar
      • 12.2.4.3.1. By Technology
      • 12.2.4.3.2. By Product and Services
      • 12.2.4.3.3. By End User
      • 12.2.4.4. Kuwait
      • 12.2.4.4.1. By Technology
      • 12.2.4.4.2. By Product and Services
      • 12.2.4.4.3. By End User
      • 12.2.4.5. South Africa
      • 12.2.4.5.1. By Technology
      • 12.2.4.5.2. By Product and Services
      • 12.2.4.5.3. By End User
      • 12.2.4.6. Nigeria
      • 12.2.4.6.1. By Technology
      • 12.2.4.6.2. By Product and Services
      • 12.2.4.6.3. By End User
      • 12.2.4.7. Algeria
      • 12.2.4.7.1. By Technology
      • 12.2.4.7.2. By Product and Services
      • 12.2.4.7.3. By End User
      • 12.2.4.8. Rest of MEA
      • 12.2.4.8.1. By Technology
      • 12.2.4.8.2. By Product and Services
      • 12.2.4.8.3. By End User

13. Competitive Landscape

  • 13.1. List of Key Players and Their Offerings
  • 13.2. Global Protein Binding Assays Company Market Share Analysis, 2023
  • 13.3. Competitive Benchmarking, By Operating Parameters
  • 13.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships)

14. Impact of Escalating Geopolitical Tensions on Global Protein Binding Assays Market

15. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

  • 15.1. Thermo Fisher Scientific, Inc.
  • 15.2. Charles River
  • 15.3. Sovicell GMBH
  • 15.4. XenoTech
  • 15.5. GE Healthcare
  • 15.6. Eurofins Scientific
  • 15.7. Creative Biolabs
  • 15.8. Evotec (Cyprotex)
  • 15.9. Bioduro
  • 15.10. BioAgilytix Labs
  • 15.11. WuXi AppTec
  • 15.12. Domainex
  • 15.13. Other Prominent Players

16. Key Strategic Recommendations

17. Research Methodology

  • 17.1. Qualitative Research
    • 17.1.1. Primary & Secondary Research
  • 17.2. Quantitative Research
  • 17.3. Market Breakdown & Data Triangulation
    • 17.3.1. Secondary Research
    • 17.3.2. Primary Research
  • 17.4. Breakdown of Primary Research Respondents, By Region
  • 17.5. Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable